Investigating the Effect of Near Infra-Red Spectroscopy (NIRS) on Early Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury.
Acute Kidney Injury
Cardiac Surgery
Near Infra-Red Spectroscopy
Journal
Anesthesiology and pain medicine
ISSN: 2228-7523
Titre abrégé: Anesth Pain Med
Pays: Netherlands
ID NLM: 101585412
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
03
10
2020
revised:
15
11
2020
accepted:
17
11
2020
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major adverse effect of cardiac surgery. The early detection of this complication can improve the quality of postoperative care and help prevent this phenomenon. In this prospective descriptive-analytical study, 148 patients were enrolled, 107 of whom were selected for analysis between February and September 2019 in the Cardiac Surgery Unit of Golestan Hospital, Ahvaz, Iran. Kidney tissue oxygen saturation was measured at multiple definite times during surgery. Hemoglobin, blood urea nitrogen, creatinine, and lactate were measured during and 48 hours after the surgery. Forty-one patients were diagnosed with CSA-AKI according to the KDIGO criteria. Parametric and non-parametric analyses showed no significant difference between the CSA-AKI and non-CSA-AKI groups in the demographic parameters. Repeated measures ANOVA showed no significant difference in parameters, except for BUN. Repeated measures ANOVA showed a significant difference between both groups and time factors (P < 0.001, P = 0.0006, respectively). The ROC curve analyses showed that in a single point of time, the difference in the middle of CPB time from baseline had a high value in the prediction of AKI (AUC: 0.764; CI: 0.57 - 0.951). Kidney saturation monitoring could be considered in cardiac surgery for the rapid detection of CSA-AKI. Although kidney tissue saturation is not correlated directly to the arterial oxygen saturation, the physician and the surgery team can predict the chance of acute kidney injury.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major adverse effect of cardiac surgery. The early detection of this complication can improve the quality of postoperative care and help prevent this phenomenon.
METHODS
METHODS
In this prospective descriptive-analytical study, 148 patients were enrolled, 107 of whom were selected for analysis between February and September 2019 in the Cardiac Surgery Unit of Golestan Hospital, Ahvaz, Iran. Kidney tissue oxygen saturation was measured at multiple definite times during surgery. Hemoglobin, blood urea nitrogen, creatinine, and lactate were measured during and 48 hours after the surgery.
RESULTS
RESULTS
Forty-one patients were diagnosed with CSA-AKI according to the KDIGO criteria. Parametric and non-parametric analyses showed no significant difference between the CSA-AKI and non-CSA-AKI groups in the demographic parameters. Repeated measures ANOVA showed no significant difference in parameters, except for BUN. Repeated measures ANOVA showed a significant difference between both groups and time factors (P < 0.001, P = 0.0006, respectively). The ROC curve analyses showed that in a single point of time, the difference in the middle of CPB time from baseline had a high value in the prediction of AKI (AUC: 0.764; CI: 0.57 - 0.951).
CONCLUSIONS
CONCLUSIONS
Kidney saturation monitoring could be considered in cardiac surgery for the rapid detection of CSA-AKI. Although kidney tissue saturation is not correlated directly to the arterial oxygen saturation, the physician and the surgery team can predict the chance of acute kidney injury.
Identifiants
pubmed: 34150576
doi: 10.5812/aapm.109863
pmc: PMC8207845
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e109863Informations de copyright
Copyright © 2020, Author(s).
Déclaration de conflit d'intérêts
Conflict of Interests: There is no conflict of interest to be declared.
Références
Int J Nephrol Renovasc Dis. 2019 Jul 02;12:153-166
pubmed: 31303781
J Thorac Cardiovasc Surg. 2017 Sep;154(3):856-864.e4
pubmed: 28554672
Crit Care. 2011 Jun 24;15(3):R153
pubmed: 21702944
Int Immunol. 2010 Jun;22(6):433-42
pubmed: 20410256
Crit Care. 2017 Jun 17;21(1):150
pubmed: 28623953
J Urol. 1999 Jul;162(1):196-203
pubmed: 10379787
Anesth Pain Med. 2017 Aug 21;7(4):e12549
pubmed: 29430406
J Cardiothorac Vasc Anesth. 2014 Jun;28(3):564-71
pubmed: 24702816
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1054-1055
pubmed: 28549695
J Thorac Cardiovasc Surg. 2019 Jun;157(6):2340-2351.e3
pubmed: 30459107
Br J Anaesth. 2009 Dec;103 Suppl 1:i3-13
pubmed: 20007987
J Mol Med (Berl). 2009 Sep;87(9):859-64
pubmed: 19562316
Anesth Pain Med. 2017 Aug 27;7(4):e21740
pubmed: 29696106
Nat Rev Nephrol. 2017 Nov;13(11):697-711
pubmed: 28869251
J Clin Med. 2019 Dec 14;8(12):
pubmed: 31847312
PLoS One. 2014 May 14;9(5):e98028
pubmed: 24826910
BMJ Open. 2016 Jun 27;6(6):e010176
pubmed: 27354068
Drug News Perspect. 2002 Oct;15(8):477-482
pubmed: 12677185
Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5
pubmed: 19101265
J Thorac Cardiovasc Surg. 2018 Jan;155(1):256-265
pubmed: 28942979
Int J Endocrinol Metab. 2012 Spring;10(2):486-9
pubmed: 23843808
Int J Artif Organs. 2008 Feb;31(2):166-78
pubmed: 18311733
J Crit Care. 2016 Feb;31(1):130-8
pubmed: 26700607
J Thorac Cardiovasc Surg. 2019 Sep;158(3):e105-e106
pubmed: 31208801
J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2622-2623
pubmed: 30377051
Pediatr Emerg Care. 2009 Mar;25(3):150-3
pubmed: 19262423
Anaesthesiol Intensive Ther. 2016;48(1):41-8
pubmed: 26966109
J Pharmacol Exp Ther. 2005 Mar;312(3):1170-8
pubmed: 15572648
Nephrol Dial Transplant. 2008 Jan;23(1):91-100
pubmed: 17670769
Int J Artif Organs. 2008 Feb;31(2):158-65
pubmed: 18311732
J Thorac Cardiovasc Surg. 2019 Jul 4;:
pubmed: 31280892